Market Research Reports® Inc. - Better Reports, Better Decisions /blog/2018/05 en Therapeutic Market of Narcolepsy in Seven Major Markets Shall Reach up to USD 2.4 Billion by 2027 /blog/2018/05/28/therapeutic-market-narcolepsy-seven-major-markets-shall-reach-usd-24-billion-2027 <div class="field field-name-body field-type-text-with-summary field-label-hidden"> <div class="field-items"> <div class="field-item even"><div> <div> Narcolepsy is a chronic neurological / brain disorder which involves poor control of sleep and wakefulness.</div> <div>  </div> <div> The disease is classically a tetrad of symptoms including excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, and hypnagogic</div>...</div></div> </div> </div> Mon, 28 May 2018 11:13:59 +0000 Staff 1783862 at 7 Major Market Size for Spinal Muscular Atrophy (SMA) was Estimated to be 825 Million in 2017 /blog/2018/05/23/7-major-market-size-spinal-muscular-atrophy-sma-was-estimated-be-825-million-2017 <div class="field field-name-body field-type-text-with-summary field-label-hidden"> <div class="field-items"> <div class="field-item even"><div> <p> Spinal Muscular Atrophy [SMA] is a rare hereditary neuromuscular disorder caused by Bi-allelic mutation of survival motor neuron gene 1 (SMN1). </p> <p> <br /> In healthy people this gene produces a protein required by the muscle controlling nerves. In the deficiency of this protein</p>...</div></div> </div> </div> Wed, 23 May 2018 08:12:58 +0000 Staff 1783305 at